Home
  >  
Section 37
  >  
Chapter 36,939

A bio-nanocapsule containing envelope protein domain IIi of Japanese encephalitis virus protects mice against lethal Japanese encephalitis virus infection

Miyata, T.; Tafuku, S.; Harakuni, T.; Tadano, M.; Yoshimoto, N.; Iijima, M.; Matsuo, H.; Matsuzaki, G.; Kuroda, S.'i.; Arakawa, T.

Microbiology and Immunology 57(6): 470-477

2013


ISSN/ISBN: 1348-0421
PMID: 23773026
DOI: 10.1111/1348-0421.12055
Accession: 036938226

An engineered bio-nanocapsule (BNC) comprising modified hepatitis B surface antigen L protein was used as a physical scaffold for envelope protein domain III (D3) of Japanese encephalitis virus (JEV). At the N terminus, the BNC contained a two-tandem repeat of the Z domain (ZZ) derived from Staphylococcus aureus protein A (ZZ-BNC). The Lys-rich ZZ moiety exposed on the surface of ZZ-BNC was used for chemical conjugation with the JEV D3 antigen, which had been expressed and purified from Escherichia coli. Immunization of mice with D3 loaded on the surface of ZZ-BNC (ZZ-BNC:D3) augmented serum IgG response against JEV and increased protection against lethal JEV infection. The present study suggests that innocuous recombinant antigens, when loaded on the surface of ZZ-BNC, can be transformed to immunogenic antigens.

PDF emailed within 0-6 h: $19.90